by Clinical Cancer Research
Data gleaned from preclinical models support glypican 2 (GPC2) as a viable target for chimeric antigen receptor (CAR) T-cell therapy in the setting of neuroblastoma and small cell lung cancer.
by Blood
Researchers have developed a neutralizing antibody with the potential to improve quality-of-life and survival outcomes in patients with immune-driven fibrotic skin conditions. EREG, a DC3...
by Transplantation and Cellular Therapy - The Official Journal of ASTCT
A single-site analysis concludes that using haploidentical donors for pediatric allogeneic hematopoietic cell transplantation (allo-HCT) is safe and effective when matched sibling donors (MSDs)...
by Transplantation and Cellular Therapy - The Official Journal of ASTCT
Researchers report that exposure to fludarabine (Flu), a component of lymphodepletion chemotherapy, may influence toxicity in patients undergoing treatment with idecabtagene-vicleucel (ide-cel).
The 2025-2026 respiratory viral season is approaching. With it comes the familiar challenge of protecting our most vulnerable patients — those who have undergone hematopoietic cell...
by ASTCT Advocacy Update
On Wednesday, November 12, the U.S. House of Representatives voted to approve the U.S. Senate’s proposal to reopen the federal government, ending the longest government shutdown in history.